This account manager software helped to demonstrate the appropriate role of Humira on formulary. With established competition and several new market entrants, gaining a clear picture of the category costs was a challenge for health plans. Some agents are self-injected and while others are HCP-administered. Each has its own set of indications, dosing regimens, and costs, which may differ by indication and by patient. The software helped present a clearer picture of overall costs to the plan and helped to demonstrate the value of Humira.